275 related articles for article (PubMed ID: 14532919)
1. [Five-year survival prognosis factors in patients with resectable advanced serosa exposed gastric carcinoma].
Yan-Quiroz EF; Díaz-Plasencia JA; Burgos-Chávez OA; Rojas-Vergara AM; Santillán-Medina J; Vilela-Guillén ES; Balmaceda-Fraselle T
Rev Gastroenterol Peru; 2003; 23(3):184-91. PubMed ID: 14532919
[TBL] [Abstract][Full Text] [Related]
2. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
3. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
4. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
5. [Advanced gastric carcinoma in the proximal third and half of the stomach: clinical and pathological characteristics and survival prognosis factors].
Burgos-Chávez OA; Díaz-Plasencia JA; Yan-Quiroz EF; Vilela-Guillén E; Rojas-Vergara AM; Caffo-Mendo C; Santillán-Medina J
Rev Gastroenterol Peru; 2004; 24(1):34-42. PubMed ID: 15098040
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic significance of tumor size in the survival of patients with advanced gastric carcinoma].
Díaz Plasencia JA; Yan-Quiroz EF; Burgos-Chávez OA; Santillán-Medina JP; Stewart-Vilela Guillén E; Rojas-Vergara AM
Rev Gastroenterol Peru; 2001; 21(1):21-9. PubMed ID: 12170283
[TBL] [Abstract][Full Text] [Related]
7. [Resectable stomach cancer: analysis of 134 consecutive cases].
Díaz-Plasencia J; Tantaleán E; Urtecho-Vera F; Guzmán C; Salinas-Alva E
Rev Gastroenterol Peru; 1995; 15(3):265-72. PubMed ID: 8580455
[TBL] [Abstract][Full Text] [Related]
8. Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery.
Laterza E; Giacopuzzi S; Minicozzi A; Saladino E; de Manzoni G
Ann Ital Chir; 2009; 80(2):101-6. PubMed ID: 19681290
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis significance of the TNM clinic stage for five year survival time in primary carcinoma of the gallbladder].
Arbayza-Avalos YK; Díaz-Plasencia JA; Segura-Plasencia NM; Yan-Quiroz EF
Rev Gastroenterol Peru; 2004; 24(1):21-7. PubMed ID: 15098038
[TBL] [Abstract][Full Text] [Related]
10. Choice of the surgical treatment in early gastric cancer.
Custureri F; D'Orazi V; Peparini N; Gabatel R; Urciuoli P; Patrizi G; Redler A; Di Matteo G
Hepatogastroenterology; 2004; 51(58):1210-4. PubMed ID: 15239281
[TBL] [Abstract][Full Text] [Related]
11. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
[TBL] [Abstract][Full Text] [Related]
12. [Clinic-pathologic pattern and survival range in resectable gastric carcinoma].
Díaz J; Plasencia ; Yan E; Quiroz ; Burgos O; Chávez ; Balmaceda T; Fraselle ; Patrón G; Ríos ; Santillán J; Medina
Rev Gastroenterol Peru; 2002; 22(1):19-27. PubMed ID: 11961566
[TBL] [Abstract][Full Text] [Related]
13. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
14. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study.
Persiani R; Rausei S; Pozzo C; Biondi A; Barone C; Cananzi FC; Schinzari G; D'Ugo D
Ann Surg Oncol; 2008 Aug; 15(8):2146-52. PubMed ID: 18543037
[TBL] [Abstract][Full Text] [Related]
15. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of D1 and D2 ganglionic dissection in advanced gastric cancer at Rebagliati Hospital].
Cornejo C; Portanova M
Rev Gastroenterol Peru; 2006; 26(4):351-6. PubMed ID: 17211484
[TBL] [Abstract][Full Text] [Related]
18. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
[TBL] [Abstract][Full Text] [Related]
19. Re-study of gastric cancer: analysis of outcome.
Samson PS; Escovidal LA; Yrastorza SG; Veneracion RG; Nerves MY
World J Surg; 2002 Apr; 26(4):428-33. PubMed ID: 11910474
[TBL] [Abstract][Full Text] [Related]
20. Outcome of surgical treatment for patients with scirrhous carcinoma of the stomach.
Otsuji E; Kuriu Y; Okamoto K; Ochiai T; Ichikawa D; Hagiwara A; Yamagishi H
Am J Surg; 2004 Sep; 188(3):327-32. PubMed ID: 15450843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
